Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Non-cash Items (2020 - 2025)

Treace Medical Concepts filings provide 6 years of Non-cash Items readings, the most recent being $6.1 million for Q4 2025.

  • On a quarterly basis, Non-cash Items fell 37.64% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 million, a 37.64% decrease, with the full-year FY2025 number at $6.1 million, down 37.64% from a year prior.
  • Non-cash Items hit $6.1 million in Q4 2025 for Treace Medical Concepts, down from $9.8 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $12.8 million in Q4 2022 to a low of $4.6 million in Q4 2023.
  • Median Non-cash Items over the past 5 years was $9.8 million (2024), compared with a mean of $8.7 million.
  • Biggest five-year swings in Non-cash Items: skyrocketed 195.12% in 2021 and later plummeted 64.12% in 2023.
  • Treace Medical Concepts' Non-cash Items stood at $12.1 million in 2021, then increased by 5.79% to $12.8 million in 2022, then plummeted by 64.12% to $4.6 million in 2023, then skyrocketed by 113.38% to $9.8 million in 2024, then plummeted by 37.64% to $6.1 million in 2025.
  • The last three reported values for Non-cash Items were $6.1 million (Q4 2025), $9.8 million (Q4 2024), and $4.6 million (Q4 2023) per Business Quant data.